NASDAQ:AMGN
Amgen Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Drug Manufacturers / Generalwebsite
www.amgen.comcrunchbase
amgenlinkedin
amgenfounding date
Jan 01, 1980ipo date
Jun 17, 1983
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acq...Show More
Earnings
Earnings Release in 6 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus